Compounding Pharmacy · Irving, TX · Both
Carie Boyd Pharmaceuticals Review
Carie Boyd Pharmaceuticals is a Texas-based compounding pharmacy operated by Right Value Drug Stores, LLC. The company runs an FDA-registered 503B outsourcing facility at 8400 Esters Blvd, Suite 190, Irving, TX 75063 (registered with FDA as an outsourcing facility on July 3, 2019), plus a 503A patient-specific compounding pharmacy doing business as Carie Boyd's Prescription Shop in Denton, TX (also referenced at 122 Grapevine Hwy, Hurst, TX per NPPES NPI 1205253085, Texas pharmacy license 165). The 503A pharmacy roots trace to a community pharmacy founded in 1965 in the Dallas-Fort Worth area. For GLP-1 weight management, Carie Boyd markets a sublingual semaglutide suspension compounded exclusively with commercially available Rybelsus tablets in a SubMagna sublingual base (starting dose 1 mg/day, titrated to ~1.5 mg/day); no public marketing was found for compounded tirzepatide. The company received an FDA Warning Letter on December 17, 2024 (reference 694687) citing 503B compliance and labeling deficiencies, and a prior Warning Letter on September 20, 2021 (reference 610751) following a 2019 inspection. Both warning letters reduce confidence in this pharmacy for telehealth-provider sourcing relative to peers without active FDA enforcement on file.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Top-Rated GLP-1 Partners
Not sourced from Carie Boyd Pharmaceuticals — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
No insurance needed · HSA/FSA eligible · vetted by our editors
Gala
Compounded GLP-1/GIP combo on a yearly plan with free shipping
Starting price: $149/mo
Get started →Read review Gala →TMates
Nationwide compounded GLP-1 availability including Puerto Rico
Starting price: $249/mo
Get started →Read review TMates →Trimi Health
Budget-conscious shoppers
Starting price: $99/mo
Get started →Read review Trimi Health →| Provider | Starting price | |
|---|---|---|
8.2Gala | $149/mo | Get started → |
6.9TMates | $249/mo | Get started → |
7.9Trimi Health | $99/mo | Get started → |
8.0ShedRx | $149/mo | Get started → |
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed
Carie Boyd Pharmaceuticals has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.
Regulatory Actions
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
Medium confidence · Last verified 2026-05-28 via Eli Marsden · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology — as of August 2026
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.